Tag: InMed

William SumnerMay 11, 2018
cOwzhBIrKPuwmkM.jpeg
BusinessFinancialPublic

InMed Pharmaceuticals Reports Increased Losses in Third Quarter Financial Results

3min00
InMed Pharmaceuticals (IN), a cannabinoid-based biopharmaceutical company, today reported its financial results for the company’s third quarter of the fiscal year 2018, which ended on March 31, 2018. Most recently InMed commenced trading on the Toronto Stock Exchange on March 26, 2018 as well as upgraded to OTCQX from the OTCQB® Venture Market on May […]
CONTINUE READING
StaffMarch 23, 2018
daily_hit004-1280x533.png
Daily Hit

The Daily Hit: Today’s Cannabis Briefs

2min00
Here are the day’s cannabis news briefs for March 23, 2018. A spending bill passed by Congress early Friday contains language that renews restrictions on the use of federal funds to interfere with state medical marijuana programs. While the president made it sound like he wouldn’t sign the bill, the latest news is that he does intend […]
CONTINUE READING
Debra BorchardtMarch 2, 2018
shutterstock_685015738-1280x1280.jpg
BusinessDaily Hit

The Daily Hit: Today’s Cannabis Briefs

5min00
InMed Pharmaceuticals InMed Pharmaceuticals Inc. (IMLFF) announced that it has received conditional approval from the Toronto Stock Exchange to list its common shares on the TSX. Final approval of the listing on the TSX remains subject to InMed fulfilling certain customary listing conditions of the TSX on or before the TSX-imposed deadline of May 29, […]
CONTINUE READING
William SumnerMarch 2, 2018
shutterstock_560570911.jpg
Business

CannTrust, InMed Gain Approval To List On The TSX

3min00
CannTrust Holdings Inc. (TRST), a licensed medical cannabis producer, announced today that is has been granted approval to commence trading on the Toronto Stock Exchange (TSX), effective March 5, 2018. Shares of the company will continue to trade under the symbol TRST. Recently the company was awarded a Health Canada Sales License for the 250,000 […]
CONTINUE READING
StaffOctober 26, 2017
shutterstock_626461436.jpg
BusinessPublic

InMed Announces Positive Eye Drop Study Results

4min00
InMed Pharmaceuticals Inc. (IMLFF) announced on Wednesday, Oct. 24th that it has positive pre-clinical data results from a study co-sponsored by InMed (Dr. Sazzad Hossain, Chief Scientific Officer) and the University of British Columbia(laboratories of Profs. Ujendra Kumar and Vikramaditya Yadav). The press release said, “The InMed-UBC study is the first ever to report hydrogel-mediated cannabinoid nanoparticle delivery to the eye, […]
CONTINUE READING

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis

READ MORE
Recent Tweets
Company

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.